Prevalence of inappropriate use of digoxin in 136 patients on digoxin and prevalence of use of warfarin or aspirin in 89 patients with persistent or paroxysmal atrial fibrillation

American Journal of Therapeutics

Volumn 16, Issue 6, 2009, Pages

  Lleva, Paul ^a   Aronow, Wilbert S ^a   Gutwein, Andrew H ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Aspirin; Digoxin; Heart failure; Paroxysmal atrial fibrillation; Persistent atrial fibrillation; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; DIGOXIN; WARFARIN;

AGED; ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; PAROXYSMAL HEART ATRIUM FIBRILLATION; PERSISTENT ATRIAL FIBRILLATION; PREVALENCE; PRIORITY JOURNAL;

AGED; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; DIGOXIN; DRUG UTILIZATION; FEMALE; HEART FAILURE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; PHYSICIAN'S PRACTICE PATTERNS; PLATELET AGGREGATION INHIBITORS; WARFARIN;

EID: 74549214360     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e31816b8fec     Document Type: Article

References (11)

1. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult-summary article. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation. Endorsed by the Heart Rhythm Society. J Am Coll Cardiol. 2005;46:1116-1143.
2. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop Guidelines for the Management of Patients with Atrial Fibrillation). Developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol. 2001; 38:1231-1265.
3. Aronow WS. Management of the older person with atrial fibrillation. J Gerontol A Biol Sci Med Sci. 2002;57A:M352-M363.
4. Rawles JM, Metcalfe MJ, Jennings K. Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin. BrHeart J. 1990;63:225-227.
5. Murgatroyd FD, Gibson SM, Baiyan X, et al. Double-blind placebo controlled trial of digoxin in symptomatic paroxysmal atrial fibrillation. Circulation. 1999;99:2765-2770.
6. Galun E, Flugelman MY, Glickson M, et al. Failure of long-term digitalization to prevent rapid ventricular response in patients with paroxysmal atrial fibrillation. Chest. 1991;99:1038-1040.
7. Sticherling C, Oral H, Horrocks J, et al. Effects of digoxin on acute, atrial fibrillation-induced changes in atrial refractoriness. Circulation. 2000;102:2503-2508.
8. Aronow W. Prevalence of appropriate and inappropriate indications for use of digoxin in older patients at the time of admission to a nursing home. J Am Geriatr Soc. 1996;44: 588-590. (Pubitemid 26137243)
9. Ahmed A, Allman RM, DeLong JF. Inappropriate use of digoxin in older hospitalized heart failure patients. J Gerontol A Biol Sci Med Sci. 2002;57A:M138-M143.
10. Gage BF, Boechler M, Doggette AL, et al. Adverse outcomes and predictors of underuse of antithrombotic therapy in Medicare beneficiaries with chronic atrial fibrillation. Stroke. 2000;31:822-827.
11. Mendelson G, Aronow WS. Underutilization of warfarin in older persons with chronic nonvalvular atrial fibrillation at high risk for developing stroke. J Am Geriatr Soc. 1998;46:1423-1424.